Patents by Inventor Irena Shur

Irena Shur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8299219
    Abstract: An isolated polypeptide is provided, comprising an amino acid sequence being at least 88% homologous to SEQ ID NO: 15 (human) as determined by BlastP using default parameters, the isolated polypeptide being capable of promoting cell adhesion and/or cell homing.
    Type: Grant
    Filed: February 28, 2011
    Date of Patent: October 30, 2012
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Dafna Benayahu, Irena Shur
  • Publication number: 20110150761
    Abstract: An isolated polypeptide is provided, comprising an amino acid sequence being at least 88% homologous to SEQ ID NO: 15 (human) as determined by BlastP using default parameters, the isolated polypeptide being capable of promoting cell adhesion and/or cell homing.
    Type: Application
    Filed: February 28, 2011
    Publication date: June 23, 2011
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Dafna BENAYAHU, Irena Shur
  • Patent number: 7919602
    Abstract: An isolated polypeptide is provided, comprising an amino acid sequence being at least 88% homologous to SEQ ID NO: 15 (human) as determined by BlastP using default parameters, the isolated polypeptide being capable of promoting cell adhesion and/or cell homing.
    Type: Grant
    Filed: August 23, 2006
    Date of Patent: April 5, 2011
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Dafna Benayahu, Irena Shur
  • Publication number: 20060292153
    Abstract: An isolated polypeptide is provided, comprising an amino acid sequence being at least 88% homologous to SEQ ID NO: 15 as determined by BlastP using default parameters, the isolated polypeptide being capable of promoting cell adhesion and/or cell homing.
    Type: Application
    Filed: August 23, 2006
    Publication date: December 28, 2006
    Applicant: Ramot At Tel Aviv University Ltd.
    Inventors: Dafna Benayahu, Irena Shur
  • Publication number: 20050250717
    Abstract: The present invention provides a chromatin remodeling protein, designated ChroM as well as alternatively spliced variants, which serves as markers for stromal precursor cells and osteogenic and muscle progenitor cells. This ChroM marker was found to be present in proliferating progenitor cells but is either absent or not predominantly present in resting cells. Antibodies directed against this ChroM marker can be used to isolate stromal progenitor cells that can differentiate into osteogenic and muscle cells. Subpopulations of human osteogenic progenitor cells can further be separated using additional markers. Due to the discovery that osteogenic progenitor sarcoma cells can be distinguished from other cells by the presence of ChroM in the nuclei or based on genetic alteration on the DNA level, a method for identifying osteosarcoma cells in a tissue sample and a method for evaluating the effectiveness of a treatment for osteogenic progenitor sarcoma are also provided.
    Type: Application
    Filed: December 20, 2002
    Publication date: November 10, 2005
    Applicant: Ramot AT Tel Aviv University Ltd.
    Inventors: Dafna Benayahu, Irena Shur